FMR1 and fragile X-associated tremor/ataxia syndrome: In this study, we aimed to identify molecular biomarkers, specifically the expression levels of some alternatively spliced isoforms at the FMR1 locus, for risk prediction, early diagnosis, and progression of developing FXTAS.